Exchange: HKSE Sector: Consumer Defensive Industry: Packaged Foods
-4.17% HKD2.76
America/New_York / 3 mai 2024 @ 04:08
FUNDAMENTALS | |
---|---|
MarketCap: | 337.45 mill |
EPS: | -1.280 |
P/E: | -2.16 |
Earnings Date: | Mar 08, 2024 |
SharesOutstanding: | 122.27 mill |
Avg Daily Volume: | 0.0834 mill |
RATING 2024-05-03 |
---|
D+ |
Strong Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
Asset | n/a | n/a | n/a | n/a | n/a | n/a |
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -2.16 | sector: PE 15.74 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.12x |
Company: PE -2.16 | industry: PE 18.70 |
DISCOUNTED CASH FLOW VALUE |
---|
HKD-2.41 (-187.22%) HKD-5.17 |
Date: 2024-05-03 |
Expected Trading Range (DAY) |
---|
HKD 2.64 - 2.88 ( +/- 4.28%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | HKD2.76 (-4.17% ) |
Volume | 0.133 mill |
Avg. Vol. | 0.0834 mill |
% of Avg. Vol | 159.46 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Besunyen Holdings Company Limited engages in the research and development, production, and sale of therapeutic tea products and pharmaceuticals in the People's Republic of China. It offers its therapeutic tea products under the Besunyen brand; herbal tea; and Besunyen Detox and Besunyen slimming tea. The company also provides functional teas, such as Besunyen Fit Tea; and LARLLY Orlistat weight-loss medicine, as well as develops, produces, and sells over-the-counter (OTC) medicines comprising Besunyen Orlistat weight-loss capsule. It sells its products through OTC pharmacies and the retail terminals in shopping malls and supermarkets; and distributors and sub-distributors, as well as through e-commerce platforms. The company was founded in 2000 and is based in Beijing, the People's Republic of China. Besunyen Holdings Company Limited is a subsidiary of Foreshore Holding Group Limited.